An injection into the eye containing antibiotics and anti-inflammatory drugs was given to patients undergoing cataract surgery as a substitute for the standard post-operative 4-week eyedrop therapy. This new treatment was evaluated for effectiveness and patient satisfaction.
The current standard protocol for people who have undergone cataract surgery requires them to self-administer topical antibiotic and anti-inflammatory eyedrops as post-operative care to prevent possible infections and treat inflammation. But it can be difficult for people to keep up with this regimen, which requires that the eyedrops be administered multiple times each day for up to six weeks after surgery.
The new therapy involves an an injection into eye during cataract surgery.  Researchers found 97% patient satisfaction with this alternative. And there was no difference in effectiveness between those who received the injection and those who had the standard eyedrop treatment.*